Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Registrati

CELZ Creative Medical Technology Holdings Inc

2,21

0,01 (0,45%)

27 Mar 2025 - Chiuso

Dati in Delay di 15 minuti

Form EFFECT - Notice of Effectiveness

Grafico Azioni Creative Medical Technol... (NASDAQ:CELZ)
Storico
Da Feb 2025 a Mar 2025

Clicca qui per i Grafici di Creative Medical Technol...

Grafico Azioni Creative Medical Technol... (NASDAQ:CELZ)
Storico
Da Mar 2024 a Mar 2025

Clicca qui per i Grafici di Creative Medical Technol...

Notizie Creative Medical Technology Holdings Inc - CELZ

Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
Giovedì 20 Marzo 2025 (7 giorni fa) • GlobeNewswire Inc.

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Mercoledì 19 Marzo 2025 (1 settimana fa) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Lunedì 17 Marzo 2025 (1 settimana fa) • Edgar (US Regulatory)

Form 8-K - Current report
Venerdì 14 Marzo 2025 (2 settimane fa) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Venerdì 14 Marzo 2025 (2 settimane fa) • Edgar (US Regulatory)

Form 8-K - Current report
Venerdì 7 Marzo 2025 (3 settimane fa) • Edgar (US Regulatory)

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds
Giovedì 6 Marzo 2025 (3 settimane fa) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Venerdì 21 Febbraio 2025 (1 mese fa) • Edgar (US Regulatory)

Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential
Giovedì 20 Febbraio 2025 (1 mese fa) • GlobeNewswire Inc.

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
Venerdì 14 Febbraio 2025 (1 mese fa) • GlobeNewswire Inc.

Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
Martedì 11 Febbraio 2025 (1 mese fa) • GlobeNewswire Inc.

Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
Mercoledì 5 Febbraio 2025 (2 mesi fa) • GlobeNewswire Inc.

Più Creative Medical Technology Holdings Inc Articoli Notizie

Euronext Developed Pacific

PSA Operating REIT

Canada Tf 1% Gn27 Cad

Constellation Software

Exchange Traded

DJ Global Developed Ex U...

WAX Protocol Tokens

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni